METHOD FOR DIAGNOSING THE RISK OF PRENEOPLASTIC AND NEOPLASTIC LIVER DISEASE IN SUBJECTS AFFECTED BY HEPATITIS

摘要

The invention herein described relates to an early and specific diagnosis method based on the use of the peptide fragment 75-99 of the URG7 protein. This peptide is used as an antigen to determine the presence of anti-URG7 antibodies in the sera of carrier subjects of the hepatitis virus, of hepatitis B in particular.